LDL PHYSICAL AND CHEMICAL-PROPERTIES IN FAMILIAL COMBINED HYPERLIPIDEMIA

被引:70
作者
HOKANSON, JE
KRAUSS, RM
ALBERS, JJ
AUSTIN, MA
BRUNZELL, JD
机构
[1] UNIV WASHINGTON,DEPT MED,DIV METAB ENDOCRINOL & NUTR,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195
[3] UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DONNER LAB,BERKELEY,CA
关键词
LDL; APO-B; GRADIENT GEL ELECTROPHORESIS; TRIGLYCERIDE; DENSITY GRADIENT ULTRACENTRIFUGATION; FAMILIAL COMBINED HYPERLIPIDEMIA;
D O I
10.1161/01.ATV.15.4.452
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial combined hyperlipidemia (FCHL) is characterized by elevations of triglyceride and/or cholesterol within families and an elevation in apoB. Although small dense LDL has been consistently associated with hypertriglyceridemia, small dense LDL persists despite reductions in triglyceride after treatment with gemfibrozil in FCHL. The current study evaluated potential differences in the distribution and chemical composition of LDL species in patients with FCHL and normolipidemic control subjects. LDL from FCHL patients was characterized by a relative abundance of a discrete LDL species with a mean peak analytic ultracentrifuge flotation rate (S-f(o)) of 4.7+/-0.5 (SEM), a density of 1.041+/-0.001 g/mL, and a particle diameter of 250+/-1 Angstrom A as assessed by gradient gel electrophoresis. The major LDL species in the control subjects had a higher mean S-f(o) rate (6.3+/-0.4), was more buoyant (density, 1.037+/-0.001 g/mL), and was larger (diameter, 262+/-2 Angstrom). In addition, in a series of six LDL fractions separated by equilibrium density gradient ultracentrifugation, particle diameters were significantly smaller in all fractions from FCHL patients compared with those from control subjects. LDL particles from patients contained less free cholesterol, cholesteryl ester, and phospholipid than LDL from control subjects. The amount of triglyceride per LDL particle, however, did not differ between FCHL patients and control subjects. Differences in flotation rate and mass of the major LDL species between patients and control subjects could not be fully accounted for by differences in plasma triglyceride levels. Thus, LDL particles from FCHL patients are smaller and more dense with less cholesterol and phospholipid. Many of these differences appear to be independent of plasma triglyceride. Differences in LDL physical and chemical properties may contribute to the increase in premature coronary disease in FCHL.
引用
收藏
页码:452 / 459
页数:8
相关论文
共 52 条
  • [1] IMMUNOASSAY OF HUMAN PLASMA APOLIPOPROTEIN-B
    ALBERS, JJ
    CABANA, VG
    HAZZARD, WR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (12): : 1339 - 1351
  • [2] AUSTIN MA, 1988, AM J HUM GENET, V43, P838
  • [3] INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    BRUNZELL, JD
    FITCH, WL
    KRAUSS, RM
    [J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 520 - 530
  • [4] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [5] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [6] BIMODALITY OF PLASMA APOLIPOPROTEIN-B LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    HOROWITZ, H
    WIJSMAN, E
    KRAUSS, RM
    BRUNZELL, J
    [J]. ATHEROSCLEROSIS, 1992, 92 (01) : 67 - 77
  • [7] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B
    BROWN, G
    ALBERS, JJ
    FISHER, LD
    SCHAEFER, SM
    LIN, JT
    KAPLAN, C
    ZHAO, XQ
    BISSON, BD
    FITZPATRICK, VF
    DODGE, HT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) : 1289 - 1298
  • [8] BRUNZELL JD, 1983, J LIPID RES, V24, P147
  • [9] MYOCARDIAL-INFARCTION IN FAMILIAL FORMS OF HYPERTRIGLYCERIDEMIA
    BRUNZELL, JD
    SCHROTT, HG
    MOTULSKY, AG
    BIERMAN, EL
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (03): : 313 - 320
  • [10] APOPROTEIN-B AND APOPROTEIN-A-1 AND CORONARY-ARTERY DISEASE IN HUMANS
    BRUNZELL, JD
    SNIDERMAN, AD
    ALBERS, JJ
    KWITEROVICH, PO
    [J]. ARTERIOSCLEROSIS, 1984, 4 (02): : 79 - 83